跳至主要内容
临床试验/NCT02839473
NCT02839473已完成3 期

Hydrosorb® Versus Control (Water Based Spray) in the Management of Radio-induced Skin Toxicity: Multicentre Controlled Phase III Randomized Trial

Institut Curie4 个研究点 分布在 1 个国家目标入组 278 人开始时间: 2010年3月1日最近更新:
适应症

试验速览

阶段
3 期
状态
已完成
入组人数
278
试验地点
4
主要终点
local treatment failure defined as interruption of radiotherapy because of skin radiotoxicity or change of local care because skin alteration.

研究概览

简要总结

The primary objective consisted of avoiding deterioration and/or restoring the integrity of the skin of patients treated by radiotherapy, right from the first signs of grade 1 or 2 radiation dermatitis.

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
Female
接受健康志愿者

入选标准

  • Women treated by normo fractionated radiotherapy for breast cancer
  • Presenting grade 1 or 2 radiation dermatitis during the treatment and who provided their written informed consent were included in the study.
  • Exclusion criteria:
  • Were male patients
  • Radiation dermatitis already treated or caused by another treatment
  • Subjects deprived of their freedom or under guardianship
  • Subjects in whom medical follow-up was impossible
  • A cancer wound or skin flap on the irradiated zone
  • A history of allergic skin reaction
  • Concomitant chemotherapy or concomitant bevacizumab therapy and bilateral irradiation.

排除标准

  • 未提供

结局指标

主要结局

local treatment failure defined as interruption of radiotherapy because of skin radiotoxicity or change of local care because skin alteration.

时间窗: through study completion, an average of 3 years

次要结局

  • quality of life assessed with the Dermatology Life Quality Index questionnaire(day0, day 14, day 28)
  • skin colorimetry measured by a colorimeter(day0, day 7, day 14, day 21, day 28)
  • pain level assessed by the visual analog pain scale(day0, day 7, day 14, day 21, day 28)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (4)

Loading locations...

相似试验